国产永久在线,激情五月色综合国产精品,五十路一区二区

熱門搜索化學品最多只顯示前20條，請點擊“搜索化學品”查看所有結(jié)果

CAS登錄號

中文名

英文名

分子結(jié)構(gòu)式

分子式

詳情

供應商

129791-92-0

利福拉齊;
3'-羥基-5'-(4-異丁基-1-哌嗪)苯噁嗪利福霉素

Rifalazil;
3'-Hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin;
5,12-Dihydroxy-2,4-dimethyl-10-[4-(2-methyl-propyl)-l-piperazinyl]-2,7-[oxy(5-acetoxy-7,9-dihydroxy-3-methoxy-4,6,8,10,14-pentamethyl-15-OXO-

Benzoic acid,4-(15-OXOretin-15-yl)-;
Retinamide,N-(4-carboxyphenyl)- (9CI);
4-Carboxyphenylretinamide;
BASF 35681;
N-(p-Carboxyphenyl)retinamide;
N-4-Carboxyphenylretinamide;
Retinamidic acid;
SRI 7167-67

Bufa-20,22-dienolide,3-(acetyloxy)-14-hydroxy-15-OXO-, (3b,5b)-;
15-OXObufalin3-acetate;
3b-Acetoxy-15-OXObufalin;
NSC 248528

Cyclopentanepropanoicacid, 3,5-dihydroxy-2-(3-oxooctyl)-, (1R,2R,3R,5S)-;
Cyclopentanepropanoicacid, 3,5-dihydroxy-2-(3-oxooctyl)-, [1R-(1a,2b,3a,5a)]-;
Cyclopentanepropionic acid,3,5-dihydroxy-2-(3-oxooctyl)- (8CI);
5,7-Dihydroxy-11-ketotetranorprostanoicacid;
5,7-Dihydroxy-11-oxotetranorprostanoic acid;
5a,7a-Dihydroxy-11-ketotetranorprostanoic acid;
5a,7a-Dihydroxy-11-oxotetranorprostanoic acid;
9a,11a-Dihydroxy-15-OXO-2,3,4,5-tetranorprostanoic acid

Chol-8(14)-en-24-oicacid, 3-hydroxy-15-OXO-, (3b,5a)- (9CI);
3-hydroxy-15-keto-chol-8(14)-en-24-oic acid

Cyclopentaneoctanoicacid, 2-(2-carboxyethyl)-3,5-dihydroxy-e-oxo-, (1R,2R,3S,5R)-;
Cyclopentaneoctanoicacid, 2-(2-carboxyethyl)-3,5-dihydroxy-e-oxo-, [1R-(1a,2b,3b,5b)]-;
Cyclopentaneoctanoic acid,2-(2-carboxyethyl)-3,5-dihydroxy-e-oxo-, stereoisomer (8CI);
5a,7a-Dihydroxy-11-ketotetranorprosta-1,16-dioicacid;
5a,7a-Dihydroxy-11-ketotetranorprostane-1,16-dioic acid;
5a,7a-Dihydroxy-11-oxotetranorprosta-1,16-dioic acid;
5a,7a-Dihydroxy-11-oxotetranorprostane-1,16-dioic acid;
9a,11a-Dihydroxy-15-OXO-2,3,4,5-tetranorprosta-1,20-dioicacid;
PGF-M;
Prostaglandin F-M

Glycine,N-[(13-cis)-15-OXOretin-15-yl]- (9CI);
Glycine,N-[3,7-dimethyl-1-oxo-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenyl]-,(Z,E,E,E)-

Hexadecanoic acid,15-OXO-, methyl ester;
Methyl 15-OXOhexadecanoate

Kaur-16-en-18-oic acid,9,11-dihydroxy-15-OXO-, b-D-glucopyranosyl ester, (4a,11b)- (9CI);
1H-2,10a-Ethanophenanthrene,kaur-16-en-18-oic acid deriv.;
(-)-Adenostemmoside B;
Adenostemmoside B

Kauran-18-oic acid,7,12,14-trihydroxy-15-OXO-, (4b,7a,12a,14R)- (9CI);
Coetsanoicacid

Kauran-18-oic acid,9,11,16,17-tetrahydroxy-15-OXO-, (4a,11b,16a)- (9CI);
1H-2,10a-Ethanophenanthrene,kauran-18-oic acid deriv.;
(-)-Adenostemmoic acid E;
Adenostemmoic acid E

Kaur-16-en-18-oic acid,11-hydroxy-15-OXO-, b-D-glucopyranosyl ester, (4a,11b)- (9CI);
1H-2,10a-Ethanophenanthrene,kaur-16-en-18-oic acid deriv.;
Paniculoside III

Kaur-16-en-20-al,1,7,11,14-tetrahydroxy-15-OXO-, (1b,7a,11b,14R)- (9CI);
1H-2,10a-Ethanophenanthrene,kaur-16-en-20-al deriv.;
Rastronol E

Kaur-16-en-18-al,11,20-epoxy-7,11,14-trihydroxy-15-OXO-, (4b,7a,11a,14R)- (9CI);
2H-8,10a-Methano-5H-benzo[h]cyclohepta[cd]isobenzofuran,kaur-16-en-18-al deriv.;
(-)-Parvifolin B;
Macrocalyxin F;
Parvifolin B

Kauran-18-oic acid,11,16,17-trihydroxy-15-OXO-, b-D-glucopyranosyl ester, (4a,11b,16a)- (9CI);
1H-2,10a-Ethanophenanthrene,kauran-18-oic acid deriv.;
(-)-Adenostemmoside D;
Adenostemmoside D

Kaur-16-en-18-al,11,20-epoxy-7,14-dihydroxy-11-methoxy-15-OXO-, (4b,7a,11a,14R)- (9CI);
2H-8,10a-Methano-5H-benzo[h]cyclohept[cd]isobenzofuran,kaur-16-en-18-al deriv.;
(-)-Macrocalyxin B;
Macrocalyxin B

Kaur-16-en-18-al,7,12,14-trihydroxy-15-OXO-, (4b,7a,12a,14R)-;
(-)-Amethystonal;
Amethystonal;
Macrocalyxin C

Kaur-16-en-18-oic acid,13-hydroxy-15-OXO-, (4a)- (9CI);
1H-2,10a-Ethanophenanthrene,kaur-16-en-18-oic acid deriv.;
15-OXOsteviol

Kauran-18-oic acid,9,11,16,17-tetrahydroxy-15-OXO-, b-D-glucopyranosyl ester, (4a,11b,16a)- (9CI);
1H-2,10a-Ethanophenanthrene,kauran-18-oic acid deriv.;
(-)-Adenostemmoside E;
Adenostemmoside E

Kaur-16-en-18-oic acid,9,11-dihydroxy-15-OXO-, (4a,11b)- (9CI);
1H-2,10a-Ethanophenanthrene,kaur-16-en-18-oic acid deriv.;
(-)-Adenostemmoic acid B;
Adenostemmoic acid B

C20H29O5

詳情

供應商

化工產(chǎn)品